🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients

Recruitingn/aAges 18 Years - anyAllAIO-Studien-gGmbH
NCT02622581 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Open, non-interventional, prospective, multi-center clinical research platform with the main objective to assess molecular biomarker testing, treatment and outcome of patients with NSCLC or SCLC in Germany

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Patients who meet all of the following criteria are eligible for the project: * Age ≥ 18 years * Able to understand and willing to sign written Informed Consent and to complete patient-reported-outcome assessment instruments Main project (NSCLC Stage IV): * Confirmed non-small cell lung cancer (NSCLC) * Stage IV (UICC8) * Systemic therapy * Informed consent no later than four weeks after start of first-line systemic treatment Satellite NSCLC Stage I-III: * Confirmed non-small cell lung cancer (NSCLC) * Informed consent no later than four weeks after start of first anti-tumor treatment (including surgery and radiotherapy) or if first treatment is surgery no longer than 3 months after start of surgery. * Stage I-III (UICC8) * Systemic (chemo)therapy and/or radiation therapy and/or surgery Satellite SCLC * Confirmed Small cell lung cancer (SCLC) * Informed consent no later than four weeks after start of first anti-tumor treatment * Systemic (chemo)therapy and/or radiation therapy and/or surgery Exclusion Criteria: none
💊

What it tests

  • data collection
📍

Where

1 site
Pius-Hospital
Oldenburg, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy